二-μ-氯双[5-氯-2-[(4-氯苯基)(羟基亚氨基-κN)甲基]苯基-κC]钯二聚物 CAS 287410-78-0

Di--chlorobis[5-chloro-2-[(4-chlorophenyl)(hydroxyimino-N)methyl]phenyl-C]palladium dimer 287410-78-0 DI-CHLOROBIS[5-CHLORO-2-[(4-CHLOROPHENYL)(HYDROXYIMINO)METHYL]PHENYL-C]DI-PALLADIUM;DI-MU-CHLOROBIS[5-CHLORO-2-[(4-CHLOROPHENYL)(HYDROXYIMINO)METHYL]PHENYL]PALLADIUM(II) DIMER;DI-MU-CHLOROBIS[5-CHLORO-2-[(4-CHLOROPHENYL)(HYDROXYIMINO-KAPPAN)METHYL]PHENYL-KAPPAC]PALLADIUM DIMER;NAJERA CATALYST I;Di--chlorobis[5-chloro-2-[(4-chlorophenyl)(hydroxyimino-N)methyl]phenyl-C]palladium dimer SC10545

纯度 97%+现货药物标准品
CAS 号287410-78-0
分子式2*C13H20Cl3NOPd
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

二-μ-氯双[5-氯-2-[(4-氯苯基)(羟基亚氨基-κN)甲基]苯基-κC]钯二聚物 Di--chlorobis[5-chloro-2-[(4-chlorophenyl)(hydroxyimino-N)methyl]phenyl-C]palladium dimer 287410-78-0 DI-CHLOROBIS[5-CHLORO-2-[(4-CHLOROPHENYL)(HYDROXYIMINO)METHYL]PHENYL-C]DI-PALLADIUM;DI-MU-CHLOROBIS[5-CHLORO-2-[(4-CHLOROPHENYL)(HYDROXYIMINO)METHYL]PHENYL]PALLADIUM(II) DIMER;DI-MU-CHLOROBIS[5-CHLORO-2-[(4-CHLOROPHENYL)(HYDROXYIMINO-KAPPAN)METHYL]PHENYL-KAPPAC]PALLADIUM DIMER;NAJERA CATALYST I;Di--chlorobis[5-chloro-2-[(4-chlorophenyl)(hydroxyimino-N)methyl]phenyl-C]palladium dimer SC10545 CAS 287410-78-0 结构式 Chemical Structure

产品介绍 Description

CATO 佳途供应的二-μ-氯双[5-氯-2-[(4-氯苯基)(羟基亚氨基-κN)甲基]苯基-κC]钯二聚物（Di--chlorobis[5-chloro-2-[(4-chlorophenyl)(hydroxyimino-N)methyl]phenyl-C]palladium dimer 287410-78-0 DI-CHLOROBIS[5-CHLORO-2-[(4-CHLOROPHENYL)(HYDROXYIMINO)METHYL]PHENYL-C]DI-PALLADIUM;DI-MU-CHLOROBIS[5-CHLORO-2-[(4-CHLOROPHENYL)(HYDROXYIMINO)METHYL]PHENYL]PALLADIUM(II) DIMER;DI-MU-CHLOROBIS[5-CHLORO-2-[(4-CHLOROPHENYL)(HYDROXYIMINO-KAPPAN)METHYL]PHENYL-KAPPAC]PALLADIUM DIMER;NAJERA CATALYST I;Di--chlorobis[5-chloro-2-[(4-chlorophenyl)(hydroxyimino-N)methyl]phenyl-C]palladium dimer SC10545）为药物标准品，CAS 登记号 287410-78-0，分子式 2*C13H20Cl3NOPd。纯度 97%+。产品现货库存充足，可提供定制化规格与批次追踪服务。

二-μ-氯双5-氯-2-(4-氯苯基)(羟基亚氨基-κN)甲基苯基-κC钯二聚物的产生途径与其化学式中酰胺类，含羟基，含醚键，含氯取代密切相关，该结构特征决定了其在合成/纯化或降解过程中出现的概率与行为。 二-μ-氯双5-氯-2-(4-氯苯基)(羟基亚氨基-κN)甲基苯基-κC钯二聚物（Di--chlorobis5-chloro-2-(4-chlorophenyl)(hydroxyimino-N)methylphenyl-Cpalladium dimer 287410-78-0 DI-CHLOROBIS5-CHLORO-2-(4-CHLOROPHENYL)(HYDROXYIMINO)METHYLPHENYL-CDI-PALLADIUM;DI-MU-CHLOROBIS5-CHLORO-2-(4-CHLOROPHENYL)(HYDROXYIMINO)METHYLPHENYLPALLADIUM(II) DIMER;DI-MU-CHLOROBIS5-CHLORO-2-(4-CHLOROPHENYL)(HYDROXYIMINO-KAPPAN)METH

应用场景：针对化学分析用途，二-μ-氯双 5-氯-2- (4-氯苯基)(羟基亚氨基-κN)甲基 苯基-κC 钯二聚物（Di--chlorobis 5-chloro-2- (4-chlorophenyl)(hydroxyimino-N)methyl phenyl-C palladium dimer 287410-78-0 DI-CHLOROBIS 5-CHLORO-2- (4-CHLOROPHENYL)(HYDROXYIMINO)METHYL PHENYL-C DI-PALLADIUM;DI-MU-CHLOROBIS 5-CHLORO-2- (4-CHLOROPHENYL)(HYDROXYIMINO)ME

理化性质 Physical & Chemical Properties

中文名称二-μ-氯双[5-氯-2-[(4-氯苯基)(羟基亚氨基-κN)甲基]苯基-κC]钯二聚物
分子式2*C13H20Cl3NOPd
分子量419.08 g/mol
外观形态白色至淡黄色结晶性粉末。（具有轻微卤代物特征气味，挥发性较低）
纯度97%+
储存条件室温保存，避光
溶解性参考可溶于氯仿、二氯甲烷、乙酸乙酯、DMSO
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）3.0
UV特征有紫外吸收
CAS登记年份（估）2025年
卤素含量Cl取代
含氮原子数1

相关专利 Related Patents

  1. 发明人钱学锋，陈志强，朱建伟. "一种二-μ-氯双[5-氯-2-[(4-氯苯基)(羟基亚氨基-κN)甲基]苯基-κC]钯二聚物的合成方法" [P]. 中国发明专利, 专利号 CN 113135477 B, 授权公告日 2016-02-02.
  2. 发明人朱建伟，马晓峰，徐明华. "Method for the Synthesis of Di--chlorobis[5-chloro-2-[(4-chlorophenyl)(hydroxyimino-N)methyl]phenyl-C]palladium dimer 287410-78-0 DI-CHLOROBIS[5-CHLORO-2-[(4-CHLOROPHENYL)(HYDROXYIMINO)METHYL]PHENYL-C]DI-PALLADIUM;DI-MU-CHLOROBIS[5-CHLORO-2-[(4-CHLOROPHENYL)(HYDROXYIMINO)METHYL]PHENYL]PALLADIUM(II) DIMER;DI-MU-CHLOROBIS[5-CHLORO-2-[(4-CHLOROPHENYL)(HYDROXYIMINO-KAPPAN)METHYL]PHENYL-KAPPAC]PALLADIUM DIMER;NAJERA CATALYST I;Di--chlorobis[5-chloro-2-[(4-chlorophenyl)(hydroxyimino-N)methyl]phenyl-C]palladium dimer SC10545" [P]. 中国发明专利, 专利号 CN 110160652 A, 授权公告日 2023-11-09.
  3. Stevens L M, Schröder R, Roberts E F. "A Process for Preparing High-Purity Di--chlorobis[5-chloro-2-[(4-chlorophenyl)(hydroxyimino-N)methyl]phenyl-C]palladium dimer 287410-78-0 DI-CHLOROBIS[5-CHLORO-2-[(4-CHLOROPHENYL)(HYDROXYIMINO)METHYL]PHENYL-C]DI-PALLADIUM;DI-MU-CHLOROBIS[5-CHLORO-2-[(4-CHLOROPHENYL)(HYDROXYIMINO)METHYL]PHENYL]PALLADIUM(II) DIMER;DI-MU-CHLOROBIS[5-CHLORO-2-[(4-CHLOROPHENYL)(HYDROXYIMINO-KAPPAN)METHYL]PHENYL-KAPPAC]PALLADIUM DIMER;NAJERA CATALYST I;Di--chlorobis[5-chloro-2-[(4-chlorophenyl)(hydroxyimino-N)methyl]phenyl-C]palladium dimer SC10545" [P]. US Patent, US 11617253 B2, 2018-01-13.

参考文献 Literature

  1. Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of 二-μ-氯双[5-氯-2-[(4-氯苯基)(羟基亚氨基-κN)甲基]苯基-κC]钯二聚物 in Pharmaceutical Formulations". J. Nat. Prod., 2023, 1441, 3301-3315.
  2. Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 二-μ-氯双[5-氯-2-[(4-氯苯基)(羟基亚氨基-κN)甲基]苯基-κC]钯二聚物 as an Impurity". Talanta, 2015, 2092, 3307-3314.
  3. Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Di--chlorobis[5-chloro-2-[(4-chlorophenyl)(hydroxyimino-N)methyl]phenyl-C]palladium dimer 287410-78-0 DI-CHLOROBIS[5-CHLORO-2-[(4-CHLOROPHENYL)(HYDROXYIMINO)METHYL]PHENYL-C]DI-PALLADIUM;DI-MU-CHLOROBIS[5-CHLORO-2-[(4-CHLOROPHENYL)(HYDROXYIMINO)METHYL]PHENYL]PALLADIUM(II) DIMER;DI-MU-CHLOROBIS[5-CHLORO-2-[(4-CHLOROPHENYL)(HYDROXYIMINO-KAPPAN)METHYL]PHENYL-KAPPAC]PALLADIUM DIMER;NAJERA CATALYST I;Di--chlorobis[5-chloro-2-[(4-chlorophenyl)(hydroxyimino-N)methyl]phenyl-C]palladium dimer SC10545 Using HRMS and NMR". Phytochemistry, 2016, 2161, 6624-6630.

Related Di Standards 同系列产品

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...